Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1957 3
1958 1
1963 1
1964 1
1965 15
1966 25
1967 29
1968 43
1969 40
1970 63
1971 55
1972 68
1973 55
1974 73
1975 58
1976 32
1977 54
1978 44
1979 51
1980 41
1981 36
1982 47
1983 48
1984 48
1985 72
1986 68
1987 49
1988 51
1989 55
1990 46
1991 49
1992 41
1993 56
1994 38
1995 43
1996 33
1997 53
1998 47
1999 53
2000 61
2001 77
2002 83
2003 126
2004 173
2005 203
2006 249
2007 300
2008 316
2009 392
2010 443
2011 556
2012 564
2013 546
2014 620
2015 676
2016 755
2017 786
2018 835
2019 401
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

8,852 results
Results by year
Filters applied: . Clear all
Page 1
Non-alcoholic fatty liver disease.
Neuschwander-Tetri BA. BMC Med 2017 - Review. PMID 28241825 Free PMC article.
As the burden of hepatitis C abates over the next decade, non-alcoholic fatty liver disease will become the major form of chronic liver disease in adults and children and could become the leading indication for liver transplantation. This overview briefly summarizes the most recent data on the pathophysiology, diagnosis, and treatment of non-alcoholic fatty liver disease. ...
As the burden of hepatitis C abates over the next decade, non-alcoholic fatty liver disease will become the major form of chro …
Pathology of non-alcoholic fatty liver disease.
Bedossa P. Liver Int 2017 - Review. PMID 28052629
Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of lesions ranging from steatosis (Non-alcoholic Fatty Liver or NAFL) to a complex pattern with hepatocellular injury and inflammation (non-alcoholic steatohepatitis; NASH) in the absence of alcohol intake. ...When, in addition, lobular inflammation and liver cell clarification/ballooning are present, then the lesion is usually defined as NASH. ...
Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of lesions ranging from steatosis (Non-alcoholic Fatty L
Mechanisms of NAFLD development and therapeutic strategies
Friedman SL, et al. Nat Med 2018 - Review. PMID 29967350 Free PMC article.
There has been a rise in the prevalence of nonalcoholic fatty liver disease (NAFLD), paralleling a worldwide increase in diabetes and metabolic syndrome. NAFLD, a continuum of liver abnormalities from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH), has a variable course but can lead to cirrhosis and liver cancer. ...
There has been a rise in the prevalence of nonalcoholic fatty liver disease (NAFLD), paralleling a worldwide increase in diabe …
Fatty liver and FGF21 physiology.
Maratos-Flier E. Exp Cell Res 2017 - Review. PMID 28549912
Non alcoholic fatty liver disease is linked to obesity and the metabolic syndrome. As rates of obesity rise it has become the major etiology of liver dysfunction. Despite intense study the molecular mechanisms contributing to the onset of fatty liver remain debatable. Furthermore, few therapies exist and as a result dietary therapy is commonly prescribed and remains problematic. ...
Non alcoholic fatty liver disease is linked to obesity and the metabolic syndrome. As rates of obesity rise it has become the …
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.
Dulai PS, et al. Hepatology 2017 - Review. PMID 28130788 Free PMC article.
Liver fibrosis is the most important predictor of mortality in nonalcoholic fatty liver disease (NAFLD). Quantitative risk of mortality by fibrosis stage has not been systematically evaluated. ...Using fibrosis stage 0 as a reference population, fibrosis stage-specific mortality rate ratios (MRRs) with 95% confidence intervals (CIs) for all-cause and liver-related mortality were estimated. ...
Liver fibrosis is the most important predictor of mortality in nonalcoholic fatty liver disease (NAFLD). Quantitative r
Histopathology, grading and staging of nonalcoholic fatty liver disease.
Kleiner DE. Minerva Gastroenterol Dietol 2018 - Review. PMID 28948754
Nonalcoholic fatty liver disease (NAFLD) is the liver disease associated with obesity, diabetes and the metabolic syndrome. Although steatosis is a key histological feature, liver biopsies of patients with NAFLD can show a wide range of other findings, including portal and lobular inflammation, ballooning and apoptotic hepatocellular injury, Mallory-Denk bodies, megamitochondria and fibrosis. ...
Nonalcoholic fatty liver disease (NAFLD) is the liver disease associated with obesity, diabetes and the metabolic syndr …
Triggering and resolution of inflammation in NASH
Schuster S, et al. Nat Rev Gastroenterol Hepatol 2018 - Review. PMID 29740166
Nonalcoholic steatohepatitis (NASH) is considered the progressive form of nonalcoholic fatty liver disease (NAFLD) and is characterized by liver steatosis, inflammation, hepatocellular injury and different degrees of fibrosis. A central issue in this field relates to the identification of those factors that trigger inflammation, thus fuelling the transition from nonalcoholic fatty liver to NASH. ...
Nonalcoholic steatohepatitis (NASH) is considered the progressive form of nonalcoholic fatty liver disease (NAFLD) and is char …
Nonalcoholic Fatty Liver Disease.
Gaglio PJ. Clin Liver Dis 2016. PMID 27063278
Pathological features of fatty liver disease.
Yeh MM and Brunt EM. Gastroenterology 2014 - Review. PMID 25109884
Alcoholic liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD) are significant causes of chronic liver disease worldwide. ...Although steatosis can be a significant cofactor in progression of established chronic liver disease, or even development of hepatocellular carcinoma, only steatohepatitis indicates the presence of progressive liver disease in patients with NAFLD. ...
Alcoholic liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD) are significant causes of chronic liver
Nonalcoholic fatty liver disease (NAFLD): Diagnosis, pitfalls, and staging.
Koch LK and Yeh MM. Ann Diagn Pathol 2018 - Review. PMID 30312882
Nonalcoholic fatty liver disease (NAFLD) is increasingly prevalent and strongly associated with obesity, diabetes and the metabolic syndrome, not only in the Western societies, but also in most regions of the world in the 21st century. ...Benign and malignant liver tumors have also been more frequently reported with the increasing prevalence of obesity and diabetes. ...
Nonalcoholic fatty liver disease (NAFLD) is increasingly prevalent and strongly associated with obesity, diabetes and the meta …
8,852 results
Jump to page
Feedback